What is the incidence of skin reactions?
In the 6-month IMPACT RCT with T1, "skin reactions occurred in 8% of participants, which the researchers considered typical of medical-grade adhesive use”.1 Skin reactions were reported for 4.0% of T 2 participants in the 6 month REPLACE RCT and 6.5 % participants during the REPLACE additional 6 month open-access phase. With any medical device that is attached to the body, skin reactions will be experienced by some individuals2.
References
1 Bolinder, J., et al. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. The Lancet. Published online September 12, 2016 http://dx.doi.org/10.1016/S0140-6736(16)31535-5
2 Haak, T., et al. Use of Flash Glucose-Sensing Technol for 12months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes Ther DOI 10.1007/s13300-017-0255-6
